Found 5 matching trials
Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects
PHASE1The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Location
Beijing SHIJITAN Hospital
The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19
PHASE2The study is a multicenter, adaptive, randomized, double-blinded and placeb...
A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19
PHASE1The study is comprised of two parts: safety evaluation part (Phase I/II) an...
Location
Multiple Locations
The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care
PHASE2This is an adaptive, randomized, double-blinded, placebo-controlled, Phase ...
Location
Multiple Locations
To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19
PHASE2The study is a multicenter, adaptive, randomized, double-blinded and placeb...
Location
Multiple Locations